Target intelligence / Profile preview

MAP4K3 divergent transcript (MAP4K3-DT)

Target
MAP4K3-DT
Molecular classification
Long non-coding RNA (lncRNA)[3][5][7]
01

Overview

MAP4K3 divergent transcript (MAP4K3-DT) is a long non-coding RNA (lncRNA) gene located close to the protein-coding MAP4K3 gene, but does not code for a protein. As a lncRNA, it may play regulatory roles in gene expression, though its specific biological function, disease involvement, or pharmacological relevance is currently unknown. It is classified as a divergent transcript, meaning it is situated within a few hundred nucleotides of a protein-coding gene, typically transcribed in the opposite direction[3][5][7]. Key distinction: MAP4K3-DT is different from MAP4K3, which is a protein-coding gene also called GLK and is involved in cellular signaling, immune regulation, and has been studied as a potential therapeutic target in autoimmune diseases and cancer[1][4][8]. MAP4K3-DT, however, is a non-coding RNA and not a protein target. No evidence supports MAP4K3-DT as a receptor, enzyme, transporter, or other classical drug target[3][5][7].

Other names
MAP4K3-DTMAP4K3 divergent transcriptENSG00000231312NCBI 728730HGNC:54056[3]
02

Mechanism of action

Not applicable; there are no drugs targeting this lncRNA[3][7]

03

Biological functions

Unknown; general lncRNAs may have regulatory roles in gene expression, but specific functions for MAP4K3-DT are not established[3][5]
04

Disease associations

Unknown; no established role in disease[3][5][7]
05

Safety considerations

None reported; there are no drugs or interventions known for this gene[3][7]
06

Interacting drugs

None known[3][7]
07

Biomarkers

None established[3][7]

Beyond the preview

Go deeper on MAP4K3 divergent transcript (MAP4K3-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAP4K3 divergent transcript (MAP4K3-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call